ARIA side effects surface in 40% of patients on Biogen’s Alzheimer’s drug Aduhelm
Biogen's Alzheimer's disease drug Aduhelm has endured a headache of a launch, largely due to lingering questions about its true clinical benefit and how the drug won ...
Continue Reading →
